What the company does
Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-genital, glioblastoma multiforme, lung, and ovarian cancers; and human papilloma virus. It is also involved in the development of INV043, which is in Phase II clinical trial for the treatment of patients with prostate cancer; and in Phase I/II clinical trial to treat non-melanoma skin cancer, as well as for the treatment of oesophageal cancer. …
What the weekly tape is saying
IVX closed the latest completed week at 0.04 AUD. The 4-week return is -22.8% and the 12-week return is -42.1%. Trend Signal is inactive, Market Dynamics is -1.17. Setup signature: Risk-first tape with a 8/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 0.07 AUD
- Vs Trend Line
- -40.8%
- Fair Value
- 0.28 AUD
- Vs Fair Value
- -84.3%
- 52W High
- 0.20 AUD
- 52W Low
- 0.04 AUD
- Drawdown
- -78.0%
- Range Position
- 0.0%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 2
- 52W Active Breadth
- 3.8%
- Sector Scope
- AU Healthcare
- Sector Rank
- 116 of 146
- Sector Percentile
- 20.7%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
AU Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- -1.4%
- Avg 4W
- -3.6%
- Trend Breadth
- 15.0%
- Positive MD
- 39.0%
AU Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 16
- 4W Rank
- 15 of 16
- Avg 1W
- -5.1%
- Avg 4W
- -10.8%
- Trend Breadth
- 6.3%
- Positive RS
- 12.5%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.17
- 4W MD Change
- -20.1%
- Relative Strength
- -50.10
- 4W RS Change
- -33.3%
- Expectation
- Negative
- Probability
- 29.96%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 325.6K
- 13W Average
- 842.0K
- 52W Average
- 601.6K
- Vs 13W
- 0.4x
- Vs 52W
- 0.5x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 6.3%
- 52W Volatility
- 8.3%
- Upside Weeks
- 16
- Downside Weeks
- 32
- Downside Breadth
- 61.5%
- Avg Gain / Loss
- 6.9% / -6.4%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- ASX
- Country
- AU
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- AUD
- Market Cap
- 4.3M
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 0.04 AUD | -8.3% | 0.07 AUD | 0.28 AUD | -1.17 | -50.10 | 325.6K | Off |
| 5 Jun 2026 | 0.05 AUD | 9.1% | 0.08 AUD | 0.28 AUD | -1.17 | -45.56 | 645.0K | Off |
| 29 May 2026 | 0.04 AUD | -10.2% | 0.08 AUD | 0.29 AUD | -1.13 | -51.49 | 728.5K | Off |
| 22 May 2026 | 0.05 AUD | -14.0% | 0.08 AUD | 0.29 AUD | -1.01 | -46.13 | 4.5M | Off |
| 15 May 2026 | 0.06 AUD | -1.7% | 0.08 AUD | 0.30 AUD | -0.98 | -37.59 | 256.4K | Off |
| 8 May 2026 | 0.06 AUD | -6.5% | 0.08 AUD | 0.30 AUD | -0.99 | -37.86 | 718.9K | Off |
| 1 May 2026 | 0.06 AUD | 0.0% | 0.08 AUD | 0.30 AUD | -1.04 | -34.09 | 810.8K | Off |
| 24 Apr 2026 | 0.06 AUD | 5.1% | 0.08 AUD | 0.31 AUD | -1.12 | -35.10 | 1.8M | Off |
| 17 Apr 2026 | 0.06 AUD | -11.9% | 0.09 AUD | 0.31 AUD | -1.06 | -39.93 | 281.1K | Off |
| 10 Apr 2026 | 0.07 AUD | -4.3% | 0.09 AUD | 0.32 AUD | -0.88 | -32.59 | 222.5K | Off |
| 3 Apr 2026 | 0.07 AUD | -6.7% | 0.09 AUD | 0.32 AUD | -0.69 | -27.23 | 177.6K | Off |
| 27 Mar 2026 | 0.07 AUD | -1.3% | 0.09 AUD | 0.33 AUD | -0.44 | -22.20 | 372.2K | Off |
| 20 Mar 2026 | 0.08 AUD | -3.8% | 0.09 AUD | 0.33 AUD | -0.19 | -20.92 | 173.7K | Off |
| 13 Mar 2026 | 0.08 AUD | 1.3% | 0.09 AUD | 0.33 AUD | 0.04 | -20.50 | 48.8K | Off |